abstract: Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals (Brazil, Uruguay and Argentina)

full free access: PROTECT study - Dalteparin versus Unfractionated Heparin in Critically Ill Patients — NEJM (venous thromboembolism-blood clots)

"Venous thromboembolism is an important complication of critical illness.....cont'd

The PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group

Methods - Study Design

The trial was conducted in 67 ICUs in academic and community hospitals in Canada, Australia, Brazil, Saudi Arabia, the United States, and the United Kingdom. Recruitment began in May 2006 and, as projected, was completed in 4 years. The trial protocol is available with the full text of this article at NEJM.org.7

About INCTR - INCTR – International Network for Cancer Treatment and Research

INCTR is located in Brussels.
It currently has branches in Brazil, Canada, Egypt, France, Nepal and the USA and offices in Cameroon, India, Tanzania and the UK.

Reports:

• A Decade of INCTR: Challenges and Opportunities
• Panel Discussion: Towards A Global Cancer control Program
• Report on Evolution of Pathology Program
• Oncology Nursing Program
• Psychosocial Program
• Development of an INCTR Faculty and Partnerships with Universities
• Open Educational Resources for Cancer (OERC): Two Years of Progress
• Report on Telepathology Meeting, Ile-Ife, Nigeria

2010 newsletter:

"In 2010, cancer overtook ischaemic heart disease as the leading cause of death in the world. While different groupings of diseases (e.g., combining all cardiovascular disease or dividing cancer into many different types) would produce a different rank order, the point should not be missed that cancer can no longer be ignored by global health policy-makers as a major cause of disability or death, as well as economic loss......."